These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27 related articles for article (PubMed ID: 28681774)
1. A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy. Lapchak PA Transl Stroke Res; 2015 Apr; 6(2):99-103. PubMed ID: 25637174 [No Abstract] [Full Text] [Related]
2. Perfusion- and diffusion-weighted MR imaging-guided therapy of vertebral artery dissection: intraarterial thrombolysis through an occipital vertebral anastomosis. Restrepo L; Pradilla G; Llinas R; Beauchamp NJ AJNR Am J Neuroradiol; 2003 Oct; 24(9):1823-6. PubMed ID: 14561610 [TBL] [Abstract][Full Text] [Related]
3. Letter regarding the article "Stroke in a young adult: looking beyond the diffusion-weighted imaging sequence". Mannino M; Valeria T; Gasparro A; Matilde G; Daniele LC Neurol Sci; 2024 Jul; 45(7):3521-3522. PubMed ID: 38441789 [No Abstract] [Full Text] [Related]
4. Sensitivity of diffusion- and perfusion-weighted imaging for diagnosing acute ischemic stroke is 97.5%. Simonsen CZ; Madsen MH; Schmitz ML; Mikkelsen IK; Fisher M; Andersen G Stroke; 2015 Jan; 46(1):98-101. PubMed ID: 25388415 [TBL] [Abstract][Full Text] [Related]
5. Thrombolysis for acute stroke in patient with systemic lupus erythematosus: A case report. Majdak MR; Vuletić V J Neurol Sci; 2016 Feb; 361():7-8. PubMed ID: 26810507 [No Abstract] [Full Text] [Related]
6. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis? Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681 [TBL] [Abstract][Full Text] [Related]
7. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro. Schellinger PD; Fiebach JB Stroke; 2005 May; 36(5):1104-5. PubMed ID: 15790944 [No Abstract] [Full Text] [Related]
8. Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: con. Zivin JA Stroke; 2005 May; 36(5):1105-6. PubMed ID: 15790943 [No Abstract] [Full Text] [Related]
9. Fluctuation of diffusion-weighted imaging and apparent diffusion coefficient in acute stroke following tissue plasminogen activator administration. Chertcoff AS; Chomont J; Bandeo L; Pantiu F; Roca CU; Bonardo P; Rugilo C; Reisin R Neurol India; 2017; 65(4):889-890. PubMed ID: 28681774 [No Abstract] [Full Text] [Related]
10. Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis. Maiser SJ; Georgiadis AL; Suri MF; Vazquez G; Lakshminarayan K; Qureshi AI Int J Stroke; 2011 Feb; 6(1):25-32. PubMed ID: 21205237 [TBL] [Abstract][Full Text] [Related]